Investor profile
Fidelity Management & Research Company LLC has backed 9 European tech companies across 9 funding rounds between 2021 and 2025, joining rounds totalling €2.6B. Most active in Healthtech and Software. Data as of 7 Aug 2026.
Also recorded as: Fidelity Management & Research
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Nscale | UK | 1 | €937M |
| Oura Health | Finland | 1 | €774M |
| Kry | Sweden | 1 | €262M |
| Quell Therapeutics | UK | 1 | €138M |
| Algolia | France |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Nscale | Series B | €937M | 2025-09 |
| Oura Health | Series D+ | €774M | 2025-10 |
| Kry | Series D+ | €262M | 2021-04 |
| Quell Therapeutics |
| 1 |
| €126M |
| JUMO | UK | 1 | €104M |
| MMI | Italy | 1 | €102M |
| Agomab Therapeutics | Belgium | 1 | €95M |
| T-knife | Germany | 1 | €93M |
| Series B |
| €138M |
| 2021-11 |
| Algolia | Series D+ | €126M | 2021-07 |
| JUMO | Other | €104M | 2021-11 |
| MMI | Series C | €102M | 2024-02 |
| Agomab Therapeutics | Series C | €95M | 2023-10 |
| T-knife | Series B | €93M | 2021-08 |
